Medikamente

ZORA Publikationsliste

Publikationen

• Gouzoulis-Mayfrank, E., Majic, T., & Schaub, M. P. (2025). Stimulanzien vom Amphetamin-Typ In A. Batra, F. Moggi, M. Walter, & M. Soyka (Eds.), Suchtmedizin (pp. 235–256). Elsevier. https://doi.org/10.1016/b978-3-437-21074-7.00014-9
• Repantis, D., Maier, L. J., & Heuser, I. (2016). Correspondence arising: Modafinil for cognitive neuroenhancement in health non-sleep-deprived-subjects European Neuropsychopharmacology, 26, 392–393. https://doi.org/10.1016/j.euroneuro.2015.12.016
• Maier, L. J., Haug, S., & Schaub, M. P. (2016). Author’s response on Arria (2016): Intention matters-using the terminology ‘pharmacological neuroenhancement’ as a behavioural definition based on the assumed functionality. Addiction, 111, 938–939. https://doi.org/10.1111/add.13331
• Liakoni, E., Schaub, M. P., Maier, L. J., Glauser, G.-V., & Liechti, M. E. (2015). The Use of Prescription Drugs, Recreational Drugs, and “Soft Enhancers” for Cognitive Enhancement among Swiss Secondary School Students. PLoS ONE, 10, e0141289. https://doi.org/10.1371/journal.pone.0141289
• Maier, L. J., Haug, S., & Schaub, M. P. (2015). The importance of stress, self-efficacy, and self-medication for pharmacological neuroenhancement among employees and students Drug and Alcohol Dependence, 156, 221–227. https://doi.org/10.1016/j.drugalcdep.2015.09.012
• Maier, L. J., Wunderli, M. D., Vonmoos, M., Römmelt, A. T., Baumgartner, M. R., Seifritz, E., Schaub, M. P., & Quednow, B. B. (2015). Pharmacological cognitive enhancement in healthy individuals: a compensation for cognitive deficits or a question of personality? PLoS ONE, 10, e0129805. https://doi.org/10.1371/journal.pone.0129805
• Maier, L. J., & Schaub, M. P. (2014). „Doping“ am Arbeitsplatz und in der Bildung in der Schweiz ISGF. http://www.isgf.ch/
• Schaub, M. P., & Bachmann, A. (2013). Stimulanzien: vielschichtige Konsumphänomene erfordern diversifizierte Angebote SuchtMagazin, 39, 5–9. https://doi.org/10.5169/seals-800036
• Rehm, J., & Weekes, J. (2005). Abuse of controlled prescription drugs In CCSA (Ed.), Substance Abuse in Canada: current challenges and choices (pp. 30–37). Canadian Centre on Substance Abuse.
• Frick, U., Lerch, S., Rehm, J., & Crotti, C. (2004). Pilotstudie zur Rezeptierung von Benzodiazepinen in der Schweiz: Beeinflusst die kognitive Verfügbarkeit von Gesetzesvorschriften das ärztliche Verschreibungsverhalten? Schriftenreihe der Akademie für öffentliches Gesundheitswesen, 66, 499–504. https://doi.org/10.1055/s-2004-813451